In turn, MASLD exacerbates systemic inflammation via pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and Interleukin 6 (IL-6), and adipokines like leptin and adiponectin [4]. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.